Global Health Limited (MEDANTA) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch
Global Health Limited, the operator of the Medanta hospital chain, faces a critical quarter as it balances the aggressive ramp-up of its Noida facility against rising operational costs. Investors will be focused on whether the Noida EBITDA loss continues to narrow toward the targeted H2 FY27 breakeven and how the company manages margin pressure amidst significant clinical talent expansion.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 1,196 Cr |
| Previous quarter PAT | Rs. 142 Cr |
| Previous quarter EBITDA margin | 24.3% |
| Market cap | Rs. 36,862.32 Cr |
| CMP | Rs. 1,371.0 |
Global Health Limited Q1 Results Date and Time
The board meeting is scheduled for July 30, 2026, to consider the unaudited Q1 FY27 financial results.
The earnings conference call is scheduled for July 31, 2026, at 2:00 PM IST, hosted by JM Financial with participation from Dr. Naresh Trehan, Pankaj Sahni, and Yogesh Gupta.
What to expect from Global Health Limited's Q1 FY27 results
The company is expected to demonstrate revenue growth ahead of the Q1 FY26 base of Rs. 1,051 Cr, supported by the full-quarter contribution of brownfield bed additions and a stable ARPOB trend. The Noida facility's EBITDA loss is likely to narrow from the Rs. 23.6 Cr reported in Q4 FY26, as management targets cash-positive operations within a 3–4 month window from May 2026.
While consolidated EBITDA margins will face pressure from the 29.8% YoY growth in employee benefits expense seen in FY26, the ongoing margin expansion in the mature portfolio is expected to partially offset the Noida drag. Investors should monitor the impact of the new CGHS portal transition on receivable cycles, which historically take 6–9 months to realize.
Q1 capital expenditure is expected to track toward the annual guidance of Rs. 800–900 Cr, with focus on the Varanasi, Guwahati, and Indore cancer unit projects.
Key Things To Watch
Noida Performance vs Guidance: Tracking the path to H2 FY27 breakeven.
- Quarterly EBITDA loss trajectory relative to Q4 FY26 loss of Rs. 23.6 Cr.
- Occupancy progress from the ~30% level reported as of May 2026 toward the 40–45% breakeven threshold.
Capex Adherence & Project Updates: Monitoring execution of the Rs. 800–900 Cr FY27 capex plan.
- Q1 FY27 spend vs full-year guidance of Rs. 800–900 Cr.
- Status of Varanasi definitive agreement, Guwahati construction, and Indore cancer unit opening.
Risks and headwinds to monitor: Operational and regulatory factors impacting cash flow and margins.
- Potential working capital strain from the new CGHS portal migration launched May 21, 2026.
- Competitive pressure from two new hospitals expected in Gurgaon by Sep–Oct 2026.
- Full-quarter impact of the 550+ clinicians onboarded during FY26 on employee benefit expenses.
Ask about this
Ask Cofacto a question about this company. Answers cite filings and company data.
Frequently Asked Questions
What is the status of the Noida hospital's breakeven timeline?
Management expects the Noida facility to turn cash-positive within 3–4 months from their May 2026 update, targeting H2 FY27 for full EBITDA breakeven. This depends on occupancy reaching the 40% to 45% range.
How is the company managing its clinical talent acquisition costs?
The company onboarded 550+ doctors in FY26, which contributed to a 29.8% YoY increase in employee benefits expense. Management noted that while hiring remains active, the bulk of the ramp-up hiring for Noida is now complete.
Are there any updates on the Gurgaon medical college project?
The company received a Letter of Intent from the Government of Haryana on June 12, 2026, for 150 MBBS seats at the Gurugram campus. Management is currently evaluating the project's capex implications and partnership structure.
Related
- Global Health Ltd (MEDANTA) Q1 FY27 Results Analysis: Revenue Surges 26.5%, EBITDA Margin Misses GuidanceQ1 FY2026-2027 Results Analysis
- Global Health Ltd (MEDANTA) Q1 FY27 Earnings Call: Plans Rs.4,850 Cr Capex for 2,950 Beds, Guides Earlier Noida EBITDA BreakevenQ1 FY2026-2027 Earnings Call
- Global Health Limited Q4 Results 2026 Preview: Date, Time, Expectations & Key Things To WatchQ4 FY2025-2026 Preview